Pfizer’s counterattack against 13 domestic companies
Pfizer which successfully protected the ‘Lyrica’ use patent started to counterattack. It has continued lawsuits against domestic companies which launched generics.
Pfizer Pharmaceuticals Korea filed a damage suit accusing of using the Lyrica’s(pregabalin) pain indications against CJ HealthCare ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
